Literature DB >> 2177497

Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart.

M Loebe1, S Schüler, O Zais, H Warnecke, E Fleck, R Hetzer.   

Abstract

In heart transplantation, accelerated graft arteriosclerosis leading to late postoperative graft failure is still an unsolved problem, and its pathogenesis is poorly understood. The existence of multiple underlying mechanisms has been discussed without conclusive results. In kidney transplantation, a negative influence of cytomegalovirus infection on long-term graft function and patient survival could be demonstrated. To evaluate the role of this infection on the incidence of coronary artery disease in the transplanted heart, we have analyzed the cytomegalovirus serostatus in 38 long-term survivors of orthotopic heart transplantation. In 14 patients (group A) graft arteriosclerosis was diagnosed by means of coronary angiography. In 24 patients (group B) the coronary vessels showed no pathologic findings. In 10 patients (71%) of group A serologic study showed evidence of cytomegalovirus infection, whereas only five patients (24%) of group B revealed cytomegalovirus infection. In two further patients of this group herpes zoster infection occurred (p less than 0.0001). Cytomegalovirus infection seems to be an important factor in the development of accelerated graft arteriosclerosis in the transplanted heart.

Entities:  

Mesh:

Year:  1990        PMID: 2177497

Source DB:  PubMed          Journal:  J Heart Transplant        ISSN: 0887-2570


  12 in total

1.  Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells.

Authors:  Y F Zhou; E Guetta; Z X Yu; T Finkel; S E Epstein
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 2.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 3.  Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.

Authors:  H Hebart; L Kanz; G Jahn; H Einsele
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 4.  Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease?

Authors:  J L Mehta; F Romeo
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

5.  Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV.

Authors:  Gretchen L Bentz; Marta Jarquin-Pardo; Gary Chan; M Shane Smith; Christian Sinzger; Andrew D Yurochko
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

6.  Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.

Authors:  P Koskinen; K Lemström; C Bruggeman; I Lautenschlager; P Häyry
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

7.  Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence.

Authors:  M Shane Smith; Gretchen L Bentz; J Steven Alexander; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

9.  Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience.

Authors:  A H Balk; W Weimar; P H Rothbarth; K Meeter; H J Metselaar; B Mochtar; M L Simoons
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.